Page 612 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

590 PART IV Specific Malignancies in the Small Animal Patient

180. Kook PH, Boretti FS, Hersberger M, et al.: Urinary catecholamine 202. Arenas C, Perez-Alenza D, Melian C: Clinical features, outcome
and metanephrine to creatinine ratios in healthy dogs at home and and prognostic factors in dogs diagnosed with non-cortisol-secret-
in a hospital environment and in 2 dogs with pheochromocytoma, ing adrenal tumours without adrenalectomy: 20 cases (1994-2009),
VetBooks.ir 181. Kook PH, Grest P, Quante S, et al.: Urinary catecholamine and 203. Baum JI, Boston SE, Case JB: Prevalence of adrenal gland masses
Vet Rec 173:501, 2013.
J Vet Intern Med 21:388–393, 2007.
metadrenaline to creatinine ratios in dogs with a phaeochromocy-
toma, Vet Rec 166:169–174, 2010. as incidental findings during abdominal computed tomography in
dogs: 270 cases (2013-2014), J Am Vet Med Assoc 249:1165–1169,
182. Wimpole JA, Adagra CF, Billson MF, et al.: Plasma free metaneph- 2016.
rines in healthy cats, cats with non-adrenal disease and a cat with 204. Myers 3rd NC, incidentalomas Adrenal: Diagnostic workup of
suspected phaeochromocytoma, J Feline Med Surg 12:435–440, the incidentally discovered adrenal mass, Vet Clin North Am Small
2010. Anim Pract 27:381–399, 1997.
183. Quante S, Boretti FS, Kook PH, et al.: Urinary catecholamine and 205. Bertazzolo W, Didier M, Gelain ME, et al.: Accuracy of cytology
metanephrine to creatinine ratios in dogs with hyperadrenocorti- in distinguishing adrenocortical tumors from pheochromocytoma
cism or pheochromocytoma, and in healthy dogs, J Vet Intern Med in companion animals, Vet Clin Pathol 43:453–459, 2014.
24:1093–1097, 2010. 206. Wucherer KL, Wilke V: Thyroid cancer in dogs: an update based
184. Green BA, Frank EL: Comparison of plasma free metanephrines on 638 cases (1995-2005), J Am Anim Hosp Assoc 46:249–254,
between healthy dogs and 3 dogs with pheochromocytoma, Vet 2010.
Clin Pathol 42:499–503, 2013. 207. Barber LG: Thyroid tumors in dogs and cats, Vet Clin North Am
185. Gostelow R, Syme H: Plasma metadrenalines in canine phaeochro- Small Anim Pract 37:755–773, 2007.
mocytoma, Vet Rec 166:538, 2010. 208. Campos M, Ducatelle R, Rutteman G, et al.: Clinical, pathologic,
186. Gostelow R, Syme HM: Plasma free metanephrine and normeta- and immunohistochemical prognostic factors in dogs with thyroid
nephrine concentrations are elevated in dogs with pheochromocy- carcinoma, J Vet Intern Med 28:1805–1813, 2014.
toma, J Vet Intern Med 25:680–681, 2011. 209. Carver JR, Kapatkin A, Patnaik AK: A comparison of medullary
187. Gostelow R, Bridger N, Syme HM: Plasma-free metanephrine and thyroid carcinoma and thyroid adenocarcinoma in dogs: a retro-
free normetanephrine measurement for the diagnosis of pheochro- spective study of 38 cases, Vet Surg 24:315–319, 1995.
mocytoma in dogs, J Vet Intern Med 27:83–90, 2013. 210. Taeymans O, Penninck DG, Peters RM: Comparison between
188. Salesov E, Boretti FS, Sieber-Ruckstuhl NS, et al.: Urinary and clinical, ultrasound, CT, MRI, and pathology findings in dogs
plasma catecholamines and metanephrines in dogs with pheochro- presented for suspected thyroid carcinoma, Vet Radiol Ultrasound
mocytoma, hypercortisolism, nonadrenal disease and in healthy 54:61–70, 2013.
dogs, J Vet Intern Med 29:597–602, 2015. 211. Deitz K, Gilmour L, Wilke V, et al.: Computed tomographic
189. Bommarito DA, Lattimer JC, Selting KA, et al.: Treatment of a appearance of canine thyroid tumours, J Small Anim Pract 55:323–
malignant pheochromocytoma in a dog using 131I metaiodoben- 329, 2014.
zylguanidine, J Am Anim Hosp Assoc 47:e188–194, 2011. 212. Bertolini G, Drigo M, Angeloni L, et al.: Incidental and noninci-
190. Edmondson EF, Bright JM, Halsey CH, et al.: Pathologic and car- dental canine thyroid tumors assessed by multidetector row com-
diovascular characterization of pheochromocytoma-associated car- puted tomography: a single-centre cross sectional study in 4520
diomyopathy in dogs, Vet Pathol 52:338–343, 2015. dogs, Vet Radiol Ultrasound 58:304–314, 2017.
191. Lentschener C, Gaujoux S, Tesniere A, et al.: Point of controversy: 213. Pollard RE, Bohannon LK, Feldman EC: Prevalence of incidental
perioperative care of patients undergoing pheochromocytoma thyroid nodules in ultrasound studies of dogs with hypercalcemia
removal-time for a reappraisal? Eur J Endocrinol 165:365–373, 2011. (2008-2013), Vet Radiol Ultrasound 56:63–67, 2015.
192. Rose L, Dunn ME, Bedard C: Effect of canine hyperadrenocor- 214. Klein MK, Powers BE, Withrow SJ, et al.: Treatment of thyroid
ticism on coagulation parameters, J Vet Intern Med 27:207–211, carcinoma in dogs by surgical resection alone: 20 cases (1981-
2013. 1989), J Am Vet Med Assoc 206:1007–1009, 1995.
193. Kol A, Nelson RW, Gosselin RC, et al.: Characterization of throm- 215. Liptak JM: Canine thyroid carcinoma, Clin Tech Small Anim Pract
belastography over time in dogs with hyperadrenocorticism, Vet J 22:75–81, 2007.
197:675–681, 2013. 216. Nadeau ME, Kitchell BE: Evaluation of the use of chemotherapy
194. Pace SL, Creevy KE, Krimer PM, et al.: Assessment of coagulation and other prognostic variables for surgically excised canine thyroid
and potential biochemical markers for hypercoagulability in canine carcinoma with and without metastasis, Can Vet J 52:994–998,
hyperadrenocorticism, J Vet Intern Med 27:1113–1120, 2013. 2011.
195. Andrade N, Rivas LR, Milovancev M, et al.: Intercostal approach 217. Haley PJ, Hahn FF, Muggenburg BA, et al.: Thyroid neoplasms in
for right adrenalectomy in dogs, Vet Surg 43:99–104, 2014. a colony of beagle dogs, Vet Pathol 26:438–441, 1989.
196. Mayhew PD, Culp WT, Hunt GB, et al.: Comparison of peri- 218. Harari J, Patterson JS, Rosenthal RC: Clinical and pathologic fea-
operative morbidity and mortality rates in dogs with noninvasive tures of thyroid tumors in 26 dogs, J Am Vet Med Assoc 188:1160–
adrenocortical masses undergoing laparoscopic versus open adre- 1164, 1986.
nalectomy, J Am Vet Med Assoc 245:1028–1035, 2014. 219. London C, Mathie T, Stingle N, et al.: Preliminary evidence for
197. Pitt KA, Mayhew PD, Steffey MA, et al.: Laparoscopic adrenalec- biologic activity of toceranib phosphate (Palladia)in solid tumours,
tomy for removal of unilateral noninvasive pheochromocytomas in Vet Comp Oncol 10:194–205, 2012.
10 Dogs, Vet Surg 45:O70–O76, 2016. 220. Radlinsky MG: Thyroid surgery in dogs and cats, Vet Clin North
198. van Sluijs FJ, Sjollema BE, Voorhout G, et al.: Results of adrenal- Am Small Anim Pract 37:789–798, 2007.
ectomy in 36 dogs with hyperadrenocorticism caused by adreno- 221. Hullinger RL: The endocrine Ssstem. In Evans HE, de Lahunta A,
cortical tumour, Vet Q 17:113–116, 1995. editors: Miller’s anatomy of the dog, ed 4, St. Louis, 2013, Elsevier,
199. Walker RG, Halliwell RE, Hall LW: The surgical treatment of pp 406–427.
Cushing’s disease in a dog, Vet Rec 90:723–726, 1972. 222. Tuohy JL, Worley DR, Withrow SJ: Outcome following simultane-
200. Mitchell JW, Mayhew PD, Culp WTN, et al.: Outcome of laparo- ous bilateral thyroid lobectomy for treatment of thyroid carcinoma
scopic adrenalectomy for resection of unilateral noninvasive adre- in dogs: 15 cases (1994-2010), J Am Vet Med Assoc 241:95–103,
nocortical tumors in 11 cats, Vet Surg 46:714–721, 2017. 2012.
201. Cook AK, Spaulding KA, Edwards JF: Clinical findings in dogs 223. Fukui S, Endo Y, Hirayama K, et al.: Identification and preserva-
with incidental adrenal gland lesions determined by ultrasonogra- tion of the parathyroid gland during total thyroidectomy in dogs
phy: 151 cases (2007-2010), J Am Vet Med Assoc 244:1181–1185, with bilateral thyroid carcinoma: a report of six cases, J Vet Med Sci
2014. 77:747–751, 2015.